ABSTRACT Aconitine and higenamine are the components of aconite root. We investigated the cardiac effects of these compounds on murine right and left atria and the interaction of higenamine with aconitine on the rate of spontaneously beating right atria. Higenamine increased the rate (EC50=38 nM) and the force of contraction (EC50=97 nM), the maximal responses being comparable with those of isoproterenol. The positive chronotropic effect of higenamine was antagonized by propranolol (30-300 nM) and practolol (10 nM 3 tM), but not by butoxamine (1 ,uM), indicating that it was a j3,-adrenoceptor-mediated action. The positive chronotropic effect of higenamine was not changed by pretreatment with reserpine (4 mg/kg, i.p., 4 hr). Aconitine (0.16 0.25 pM) induced tachyarrhythmia in right atria was attenuated by quinidine (1 pM), atropine (8.6 pM) and AF-DX 116 (8.6 pM), suggesting that aconitine activates sodium channels and muscarinic receptors. Higenamine (2.5 nM) and dobutamine (1 nM) did not cause chronotropic effects by themselves, but enhanced the aconitine-induced tachyarrhythmia. These results indicate that higenamine is a ~1-adrenoceptor full agonist in murine atria and that the aconitine-induced tachyarrhythmia is augmented by the ,31-adrenergic action of higenamine.
(30 pg/kg, i.p.) produces a decrease in heart rate to 50010 of the basal level within 20 min after administration, and this effect of aconitine is mediated by activation of muscarinic receptors in the central nervous system (13) . Interestingly, higenamine (10 pg/kg, i.p.) inhibited the bradycardia induced by aconitine in mice in vivo (13) . The present experiments were carried out first to analyze the pharmacological characteristics of the cardiac effects of higenamine and aconitine and second, to further eluci date the mechanism of interaction between aconitine and higenamine in isolated murine atria.
MATERIALS AND METHODS

Animals
Male ddY mice weighing 32-42 g (7 to 9-week-old) were used.
Preparation of isolated murine atria
Mice were sacrificed by decapitation and exsanguina tion. The thorax was opened, and the heart was rapidly re moved and placed in Krebs-Henseleit solution. The solu tion was composed of 118.4 mM NaCI, 4.69 mM KCI, 2.0 mM CaC12, 1.16 mM MgC12, 12.4 mM NaHCO3 and 5.0 mM glucose and gassed with 95076 02-507o C02 at 301C. Right and left atria were separated from the ventri cle and other tissues, respectively. The atrial preparations were connected to an isometric transducer (model UL 2GR; Minebea, Nagano) by a silk thread, and they were suspended under a resting tension of 1 mN in an organ bath containing 2.5 ml Krebs-Henseleit solution.
Experimental procedures
The right atrial preparations were equilibrated until the rate of contraction reaches a stable level of approximately 4 Hz. The left atria were electrically driven by means of field stimulation (3-msec pulse duration, 1.5-fold threshold-voltage at 4 Hz) via platinum bipolar electrodes and equilibrated for 1 hr. The stimulus pulse was generat ed by an electronic stimulator (SEN-3201; Nihon Koh den, Tokyo) and applied through an isolator (45-201J, Nihon Kohden). The receptor antagonists and ion chan nel inhibitors were allowed to act for 5 min before the application of the test drugs. The concentration-response curves of aconitine, practolol, isoproterenol and (±) higenamine were determined by cumulative administra tion. The concentration of the drugs was increased step wise every 2 min. The rate and the force of contraction were recorded on a pen-writing oscillograph (type 5108, Nihon Kohden). The rate of contraction was calculated by measuring the time required for 20 beats on the actual recordings. The rate of contraction was calculated in a similar manner after the administration of aconitine in the concentration range of 0.16-0.25 pM. Aconitine at these concentrations did not induce atrial flutter and fibril lation.
Drugs used
The following drugs were used: aconitine, lidocaine, 
Statistical analyses
Significant differences between mean values for the con trol and after administration of drugs were evaluated by means of analysis of variance (ANOVA) and the multiple range test of Newman-Kewls. The difference was consi dered to be significant when the P value was smaller than 0.05.
The Hill coefficient and pA2 values were estimated by the method of Arunlakshana and Schild (14) .
RESULTS
Chronotropic effect of higenamine on right atria
Higenamine (3 nM-3 pM) ( Fig. 1 ) and isoproterenol (0.1-100 nM) induced a positive chronotropic effect on right atria in a concentration-dependent manner. The response reached a steady level within 2 min. The max imal responses of 8.24±0.11 (n=4) and 8.07±0.1 Hz (n=4) were achieved by isoproterenol (0.1 pM) and higenamine (3 rM), respectively. The intrinsic activity of higenamine (0.98) was comparable to that of isoproter enol (1.0). The EC50 values of isoproterenol and higena mine were 1.98 nM (95% confidence limit: 1.82-2.15 nM) and 37.9 nM (32.6-44.5 nM), respectively, indicat ing that higenamine is approximately 20 times less potent than isoproterenol.
Propranolol (0.03 -0.3 pM) shifted to the right the con centration-response curves of higenamine ( Fig. 1 ) and iso proterenol in parallel. Schild plots of the antagonistic ac tion of propranolol on the positive chronotropic effect of higenamine and isoproterenol demonstrated that Hill coefficients (1.14 and 1.16) and pA2 values (7.94 and 8.06) for the antagonistic action of propranolol against the posi tive chronotropic effects of higenamine and isoproterenol were comparable, respectively.
Higenamine did not show tachyphylaxis. The positive chronotropic effect of higenamine was not inhibited by reserpine (4 mg/kg, i.p., 4 hr)-pretreatment (data not shown). The pretreatment is enough to deplete catechol amines in the heart of rat (15, 16) .
Inhibition by r31-adrenergic blocking agents of the posi tive chronotropic effect of higenamine Higenamine at 38 nM and isoproterenol at 2 nM induced a positive chronotropic action equivalent to 50% of the maximal response. A r31-adrenergic blocking agent, practolol (10 nM 3 uM), inhibited the positive chronotropic effects of 38 nM higenamine and 2 nM isoproterenol in a concentration-dependent manner in isolated right atria (Fig. 2) . In contrast, butoxamine (1 ,uM), a t32-adrenergic blocking agent, did not affect the chronotropic effects of higenamine and isoproterenol (data not shown). These results indicate that the positive chronotropic effects of higenamine and isoproterenol are mediated by 31-adrenergic receptors.
Positive inotropic effects of higenamine Higenamine (12.5 800 nM) ( respectively, indicating that higenamine is approximately 20 times less potent than isoproterenol. The intrinsic activ ity of higenamine (0.94) was comparable to that of isopro terenol (1.0).
Positive chronotropic effects of aconitine Aconitine (0.17-0.25 ,uM) induced a positive chrono tropic effect that was followed by bigeminy in the right atria (Fig. 4, upper panel) .
Quinidine, a sodium channel blocking and anti-ar rhythmic agent (class la), significantly suppressed the aconitine-induced tachycardia and bigeminy at a concen tration of 1 aM, a dose that did not affect the basal rate by itself. Lidocaine (3 NM), verapamil (10 nM) and diltia zem (10 nM) did not affect the aconitine-induced tachyar rhythmia (data not shown). 
Inhibition by muscarinic receptor antagonists of aconi tine-induced tachyarrhythmia
The muscarinic antagonist atropine (8.61tM) and the M2-selective antagonist AF-DX 116 (8.6 sM) suppressed significantly the aconitine-induced tachyarrhythmia. Scopolamine (8.6 ,uM) suppressed the aconitine-induced tachyarrhythmia to a lesser extent (Fig. 4, lower) .
Enhancement of the aconitine-induced tachyarrhythmia by higenamine and dobutamine Higenamine (2.5 nM) did not affect the rate of contrac tion, but enhanced the aconitine-induced tachyarrhyth mia in isolated right atria (Fig. 5) .
Dobutamine, a selective j31-adrenoceptor agonist, at 0.3 and 1 nM did not elicit any chronotropic effect by itself, but likewise enhanced the aconitine-induced tachyar rhythmia as shown in Fig. 6 . 
DISCUSSION
Processed aconite is frequently prescribed as a tradi tional Chinese medicine. The processed preparation of aconite contains aconitine, mesaconitine, higenamine, coryneine and many other principles. We have found by in vivo experiments in mice that aconitine produces bradycardia in association with bigeminy and that higena mine inhibited the aconitine-induced bradycardia (13) . While the effect of aconitine seems to be produced through a central muscarinic mechanism, the mechanism for higenamine-induced is unknown. Because aconitine also produces tachyarrhythmia in isolated atria (17) , the present study was performed to elucidate the mechanism of interaction between aconitine and higenamine in isolat ed murine atria.
In murine atria, higenamine elicited a concentration dependent positive chronotropic effect. The positive chronotropic effect of higenamine was inhibited by pro pranolol and the s1-antagonist practolol, but not by the 32-antagonist butoxamine, indicating that higenamine induces a positive chronotropic effect via activation of cardiac j31-adrenoceptors. The chronotropic effect of higenamine is not due to the release of catecholamines, be cause the pretreatment with reserpine did not inhibit the positive chronotropic effect of higenamine.
Higenamine, a cyclic catecholamine, has been shown to elicit a chronotropic effect on cultured rat heart cells. The effect of higenamine is antagonized by pindolol (18) . Higenamine increases the plasma cyclic AMP content in mice. The affinity of isoproterenol for the /3-adrenoceptor in turkey erythrocyte membrane is similar to that of higenamine, whereas the intrinsic activity of higenamine on cyclic AMP generation is 0.29 of that for isoproterenol (19) . /3-Adrenergic stimulation increases Ca" influx in myocardial cells by the pathway of cyclic AMP and cyclic AMP-dependent protein kinase (20) . Kimura et al. (12) have reported that higenamine shifts the concentration inotropic response curve of Ca 21 in parallel to the left in guinea pig papillary muscle. The positive inotropic action of higenamine is likely due to stimulation of cardiac adrenoceptors (11) .
Aconitine is known as an activator of the voltage-de pendent sodium channel and a partial ligand to the so dium channel (21, 22) . Aconitine produces tachyarrhyth mia in isolated atria. The concentration range of aconitine for inducing tachyarrhythmia was very narrow (0.16-0.25 rM). At concentrations higher than 0.25 pM, aconitine suppressed the rate of beating in murine atria. Quinidine, but not lidocaine, suppressed the aconitine-induced tachyarrhythmia. Though both antiarrhythmic drugs belong to the family of Na channel blocking agents, the action potential duration is prolonged by quinidine and shortened by lidocaine. Therefore the suppression in duced by quinidine may partially be due to the Na chan nel inhibition in association with prolongation of action potential duration.
Aconitine increases ACh content in isolated canine right atria (23) . Aconitine may stimulate ACh release from presynaptic nerves by activation of sodium chan nels. Cholinergic agonists and vagal stimulation potenti ate the inducibility of atrial fibrillation and tachyar rhythmias in isolated canine right atria (24) , suggesting that ACh released by aconitine may contribute to the ar rhythmogenic action of aconitine, in addition to sodium channel activation. In murine atria, muscarinic an tagonists, atropine, scopolamine, and AF-DX 116 (a selec tive M2-receptor antagonist), suppressed the tachyar rhythmia induced by aconitine. Quinidine may likewise at tenuate the release of ACh by inhibition of the sodium channel in presynaptic nerve terminals. In addition, quini dine has an anti-muscarinic effect at the receptor binding site (25, 26) . The quinidine-induced suppression of the aconitine-induced tachyarrhythmia may involve the diverse effects of this compound on muscarinic signal transduction. Verapamil and diltiazem had no effect on aconitine-induced tachyarrhythmia, indicating a less sig nificant contribution of the activation of L-type calcium channels.
Higenamine enhances the aconitine-induced tachyar rhythmia in isolated murine atria, while it inhibited the aconitine-induced bradycardia in vivo (13) . The aconit ine-induced tachyarrhythmia was likewise enhanced by dobutamine, a 131-agonist, indicating that the f3, adrenoceptor activation plays a crucial role, because higenamine stimulates 131-adrenoceptors in murine atria (Figs. 1 and 2 ).
In conclusion, activation of sodium channels and mus carinic receptors by aconitine may play a crucial role in the aconitine-induced tachyarrhythmia in murine atria. Activation of j31-adrenoceptors by higenamine as well as dobutamine augment the aconitine-induced tachyar rhythmia.
